Effects of SET and SET-CAN on the differentiation of the human promonocytic cell line U937. (Q40608068)

22 September 2017

title

Effects of SET and SET-CAN on the differentiation of the human promonocytic cell line U937. (English)

1 reference

22 September 2017

Kandilci A

1 reference

22 September 2017

Mientjes E

series ordinal

1 reference

22 September 2017

Grosveld G

series ordinal

1 reference

22 September 2017

publication date

1 February 2004

1 reference

22 September 2017

1 reference

22 September 2017

1 reference

22 September 2017

1 reference

22 September 2017

page(s)

337-340

1 reference

Characterization of the translocation breakpoint sequences of two DEK-CAN fusion genes present in t(6;9) acute myeloid leukemia and a SET-CAN fusion gene found in a case of acute undifferentiated leukemia

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403227

Cellular localization and expression of template-activating factor I in different cell types.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403227

The (6;9) chromosome translocation, associated with a specific subtype of acute nonlymphocytic leukemia, leads to aberrant transcription of a target gene on 9q34

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403227

Regulation of histone acetylation and transcription by nuclear protein pp32, a subunit of the INHAT complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403227

The oncoprotein Set/TAF-1beta, an inhibitor of histone acetyltransferase, inhibits active demethylation of DNA, integrating DNA methylation and transcriptional silencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403227

Tumor suppressor NM23-H1 is a granzyme A-activated DNase during CTL-mediated apoptosis, and the nucleosome assembly protein SET is its inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403227

HRX Leukemic Fusion Proteins Form a Heterocomplex with the Leukemia-associated Protein SET and Protein Phosphatase 2A

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403227

Novel role for the nuclear phosphoprotein SET in transcriptional activation of P450c17 and initiation of neurosteroidogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403227

Overexpression of the nucleoporin CAN/NUP214 induces growth arrest, nucleocytoplasmic transport defects, and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403227

Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403227

Apoptosis in normal and neoplastic hematopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403227

Template activating factor-I remodels the chromatin structure and stimulates transcription from the chromatin template

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403227

inferred from DOI database lookup

7 January 2021

based on heuristic

Functional domains of template-activating factor-I as a protein phosphatase 2A inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403227

inferred from DOI database lookup

7 January 2021

based on heuristic

Vitamin D analogs, leukemia and WAF1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403227

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.LEU.2403227

1 reference

Dimensions Publication ID

22 September 2017

1001954890

0 references

1 reference